PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1378592
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1378592
The Global Vascular Patches Market is estimated to be valued at US$ 380.9 Million in 2023 and is expected to exhibit a CAGR of 7.9% during the forecast period (2023-2030).
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2022 | Market Size in 2023: | US$ 380.9 Mn |
Historical Data for: | 2018 to 2021 | Forecast Period: | 2023 - 2030 |
Forecast Period 2023 to 2030 CAGR: | 7.90% | 2030 Value Projection: | US$ 648.6 Mn |
After a carotid endarterectomy, vascular patches are applied. During the endarterectomy and vascular reconstruction procedures, the patches guarantee exact closures. Surface line buttressing, peripheral vascular restoration, and other repairs all require vascular patches. Additionally, femoral, renal, and iliac endarterectomy operations use the patches. Polyester urethane is the main component of vascular patches. The elastic fabric used in patches helps stop bleeding from suture holes. Vascular patches have superior handling qualities. The patches' microporous design aids in the appropriate integration of tissues. Patches made of biological or synthetic materials are highly biocompatible and have a long mechanical life.
Vascular-Patch is manufactured from polyester-urethane and is characterized by an excellent biocompatibility and proven long-term mechanical stability. The elastic material ensures minimum suture hole bleeding and a compliance which is unmatched by any other synthetic patch.
Vascular patches are used for the closure of arteriotomy with a patch reduces the effect of neointimal hyperplasia and scarring and maintains the arterial lumen diameter after the procedure. In addition, patches are usually used to close arteriotomies in other vascular beds, such as after common femoral endarterectomy or profundaplasty
The key players in the vascular patches market are focusing on the development of technologically advanced products. Collaborations, agreements to develop technologically advanced products are expected to drive market growth over the forecast period. For instance, on June 30, 2021, Axio Biosolutions, an integrated wound care company, announced U.S. FDA 510(k) clearance of its hemostatic product, Axiostat Patch, which helps control moderate to severe bleeding in vascular procedures, surgical debridement sites, punch sites, and more.
Vascular Patches Market Detailed Segmentation: